CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-05 | Graham G. Walmsley Director | Purchase | +50,000 | $13.09 | $654K | 1,800,000 |
| 2023-11-30 | Harmon Cyrus Director | Sale 10b5-1 | −25,000 | $12.57 | $314K | 926,283 |
| 2023-11-22 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −7,095 | $13.89 | $99K | 30,664 |
| 2023-11-21 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −7,261 | $14.83 | $108K | 37,959 |
| 2023-11-21 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −200 | $15.33 | $3K | 37,759 |
| 2023-11-20 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award | +28,000 | 45,220 | ||
| 2023-09-12 | Graham G. Walmsley Director | Purchase | +508,130 | $9.84 | $5.0M | 1,668,130 |
Page 11 of 11 · 207 trades